Diagnostics start-up EverlyWell has raised $5m to expand its suite of tests, hire for leadership positions, establish partnerships and enhance product features, according to CEO Julia Cheek. The funding round was led by NextGen Venture Partners with contributions by SoGal Ventures, Full Tilt Capital and other investors. EverlyWell offers package samples that test for food sensitivity, thyroid activity, metabolism and sexual health. The tests can be ordered online and, once complete, sent to an affiliated lab. The company has raised $2m to date.
Diagnostics start-up EverlyWell has raised $2m to expand its suite of tests, hire for leadership positions, establish partnerships and enhance product features, according to CEO Julia Cheek. The funding round was led by NextGen Venture Partners with contributions by SoGal Ventures, Full Tilt Capital and other investors. EverlyWell offers package samples that test for food sensitivity, thyroid activity, metabolism and sexual health. The tests can be ordered online and, once complete, sent to an affiliated lab. The company has raised $5m to date.